CGAS and urinary bladder cancer: In order to ascertain whether the expression of four genes was influenced by the state of the cGAS-STING pathway, we employed varying concentrations of ADU-S100 (a cGAS-STING pathway agonist) to treat the T24 bladder cancer cell line, thereby inducing alterations in their expression levels.